456 related articles for article (PubMed ID: 34830282)
1. Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis.
Kimura Y; Tsukui D; Kono H
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830282
[TBL] [Abstract][Full Text] [Related]
2. Serum uric acid and the risk of cardiovascular and renal disease.
Borghi C; Rosei EA; Bardin T; Dawson J; Dominiczak A; Kielstein JT; Manolis AJ; Perez-Ruiz F; Mancia G
J Hypertens; 2015 Sep; 33(9):1729-41; discussion 1741. PubMed ID: 26136207
[TBL] [Abstract][Full Text] [Related]
3. Comorbidities in gout and hyperuricemia: causality or epiphenomena?
Sumpter NA; Saag KG; Reynolds RJ; Merriman TR
Curr Opin Rheumatol; 2020 Mar; 32(2):126-133. PubMed ID: 31876630
[TBL] [Abstract][Full Text] [Related]
4. Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profilE study.
Redon P; Maloberti A; Facchetti R; Redon J; Lurbe E; Bombelli M; Mancia G; Grassi G
J Hypertens; 2019 Feb; 37(2):380-388. PubMed ID: 30074564
[TBL] [Abstract][Full Text] [Related]
5. Association of serum uric acid and metabolic syndrome in type 2 diabetes.
Bonakdaran S; Kharaqani B
Curr Diabetes Rev; 2014 Mar; 10(2):113-7. PubMed ID: 24588601
[TBL] [Abstract][Full Text] [Related]
6. Uric acid in metabolic syndrome: From an innocent bystander to a central player.
Kanbay M; Jensen T; Solak Y; Le M; Roncal-Jimenez C; Rivard C; Lanaspa MA; Nakagawa T; Johnson RJ
Eur J Intern Med; 2016 Apr; 29():3-8. PubMed ID: 26703429
[TBL] [Abstract][Full Text] [Related]
7. Chronic kidney disease: Which role for xanthine oxidoreductase activity and products?
Polito L; Bortolotti M; Battelli MG; Bolognesi A
Pharmacol Res; 2022 Oct; 184():106407. PubMed ID: 35995347
[TBL] [Abstract][Full Text] [Related]
8. Association between serum uric acid levels and metabolic markers in patients with type 2 diabetes from a community with high diabetes prevalence.
Rafiullah M; Siddiqui K; Al-Rubeaan K
Int J Clin Pract; 2020 Apr; 74(4):e13466. PubMed ID: 31854061
[TBL] [Abstract][Full Text] [Related]
9. Comorbidities in patients with crystal diseases and hyperuricemia.
Sattui SE; Singh JA; Gaffo AL
Rheum Dis Clin North Am; 2014 May; 40(2):251-78. PubMed ID: 24703346
[TBL] [Abstract][Full Text] [Related]
10. [Is hyperuricemia a cardiovascular risk factor?].
Chizyński K; Rózycka M
Wiad Lek; 2006; 59(5-6):364-7. PubMed ID: 17017483
[TBL] [Abstract][Full Text] [Related]
11. [Hyperuricemia - more than gout : Impact on cardiovascular risk and renal insufficiency].
Sellin L; Kielstein JT; de Groot K
Z Rheumatol; 2015 May; 74(4):322-8. PubMed ID: 25962453
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.
Bove M; Cicero AF; Veronesi M; Borghi C
Vasc Health Risk Manag; 2017; 13():23-28. PubMed ID: 28223818
[TBL] [Abstract][Full Text] [Related]
13. Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout.
Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu EQ; Tawk R; Liu J; Shi L
QJM; 2013 Aug; 106(8):721-9. PubMed ID: 23620537
[TBL] [Abstract][Full Text] [Related]
14. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank.
Sandoval-Plata G; Nakafero G; Chakravorty M; Morgan K; Abhishek A
Rheumatology (Oxford); 2021 Jul; 60(7):3243-3251. PubMed ID: 33313843
[TBL] [Abstract][Full Text] [Related]
15. Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?
Shah A; Keenan RT
Curr Rheumatol Rep; 2010 Apr; 12(2):118-24. PubMed ID: 20425020
[TBL] [Abstract][Full Text] [Related]
16. Gout and Metabolic Syndrome: a Tangled Web.
Thottam GE; Krasnokutsky S; Pillinger MH
Curr Rheumatol Rep; 2017 Aug; 19(10):60. PubMed ID: 28844079
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of uric acid and fructose.
Rho YH; Zhu Y; Choi HK
Semin Nephrol; 2011 Sep; 31(5):410-9. PubMed ID: 22000647
[TBL] [Abstract][Full Text] [Related]
19. Should we be more aware of gender aspects in hyperuricemia? Analysis of the population-based German health interview and examination survey for adults (DEGS1).
Engel B; Hoffmann F; Freitag MH; Jacobs H
Maturitas; 2021 Nov; 153():33-40. PubMed ID: 34654526
[TBL] [Abstract][Full Text] [Related]
20. Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout.
Hosoya T; Ohno I; Nomura S; Hisatome I; Uchida S; Fujimori S; Yamamoto T; Hara S
Clin Exp Nephrol; 2014 Dec; 18(6):876-84. PubMed ID: 24448692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
